TGF-Β as a Marker of Ulcerative Colitis and Disease Severity

1. Sanchez-Munoz F, Dominguez-Lopez A, Yamamoto-Furusho JK. Role of cytokines in inflammatory bowel disease. World J Gastroenterol. 2008; 14: 4280-8.10.3748/wjg.14.4280273117718666314Search in Google Scholar

2. Bamias G, Kaltsa G, Ladas SD. Cytokines in the pathogenesis of ulcerative colitis. Discov Med. 2011; 11: 459-67.Search in Google Scholar

3. Mager LF, Wasmer M-HC, Rau TT, Krebs P. Cytokine-induced Modulation of Colorectal Cancer. Front Oncol 2016; 6: 1–19.10.3389/fonc.2016.00096483550227148488Search in Google Scholar

4. Landskron G, De La Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res 2014; 2014. doi:10.1155/2014/149185.10.1155/2014/14918524901008403671624901008Open DOISearch in Google Scholar

5. Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts). Clin Ter. 2006; 157: 377-86.Search in Google Scholar

6. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004; 75: 163-89.10.1189/jlb.060325214525967Search in Google Scholar

7. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol. 2010; 10: 479-489.10.1038/nri280020559326Search in Google Scholar

8. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity. 2009; 31: 331-341.10.1016/j.immuni.2009.08.00119682929Search in Google Scholar

9. Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity. 2009; 31: 321-330.10.1016/j.immuni.2009.06.02019682928Open DOISearch in Google Scholar

10. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 2008; 28: 454-467.10.1016/j.immuni.2008.03.004342450818400188Search in Google Scholar

11. Milner JD. IL-17 producing cells in host defense and atopy. Curr Opin Immunol. 2011; 23: 784-788.10.1016/j.coi.2011.09.00622019285Open DOISearch in Google Scholar

12. Kuchroo VK, Ohashi PS, Sartor RB, Vinuesa CG. Dys-regulation of immune homeostasis in autoimmune diseases. Nat Med. 2012; 18: 42-47.10.1038/nm.262122227671Search in Google Scholar

13. Ahmed M, Gaffen SL. IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev. 2010; 21: 449-453.10.1016/j.cytogfr.2010.10.005Open DOISearch in Google Scholar

14. Trinchieri G. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol. 2012; 30: 677–706.10.1146/annurev-immunol-020711-075008Open DOISearch in Google Scholar

15. Gallimore AM, Godkin A. Epithelial barriers, microbiota, and colorectal cancer. N Engl J Med. 2013; 368: 282-284.10.1056/NEJMcibr1212341Search in Google Scholar

16. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med. 2001; 194: 519-527.10.1084/jem.194.4.519Search in Google Scholar

17. Chung DR, Kasper DL, Panzo RJ, Chitnis T, Grusby MJ, Sayegh MH, et al. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol. 2003; 170: 1958-1963.10.4049/jimmunol.170.4.1958Search in Google Scholar

18. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic antiCandida albicans host defense in mice. J Infect Dis. 2004; 190: 624–631.10.1086/422329Search in Google Scholar

19. Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, Komiyama Y, et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity. 2009; 30: 108-119.10.1016/j.immuni.2008.11.009Open DOISearch in Google Scholar

20. G. Trinchieri, S. Pflanz, and R. A. Kastelein. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity. 2003;19: 641–64410.1016/S1074-7613(03)00296-6Open DOISearch in Google Scholar

21. D. A. A. Vignali and V. K. Kuchroo. IL-12 family cytokines: immunological playmakers. Nature Immunology 2012;13: 722–728.10.1038/ni.2366415881722814351Open DOISearch in Google Scholar

22. Molle C, Nguyen M, Flamand V, Renneson J, Trottein F, De Wit D, Willems F, Goldman M, Goriely S.. IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3. The Journal of Immunology 2007; 178: 7607- 7615.10.4049/jimmunol.178.12.760717548596Search in Google Scholar

23. N. D. Pennock, L. Gapin, and R. M. Kedl. IL-27 is required for shaping the magnitude, affinity distribution, and memory of T cells responding to subunit immunization. PNAS 2014; 111: 16472-16477.10.1073/pnas.1407393111424633425267651Search in Google Scholar

24. H. Yoshida and C. A. Hunter. The immunobiology of interleukin-27. Annual Review of Immunology 2015; 33: 417-443.10.1146/annurev-immunol-032414-11213425861977Search in Google Scholar

25. S. Aparicio-Siegmund and C. Garbers. The biology of interleukin-27 reveals unique pro- and anti-inflammatory functions in immunity. Cytokine and Growth Factor Reviews 2015; 26: 579-586.10.1016/j.cytogfr.2015.07.00826195434Search in Google Scholar

26. Liu C, Zhang L, Chang X, Cheng Y, Cheng H, Ye X, et al. Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer. Chinese J Cancer Res 2012; 24: 130–7.10.1007/s11670-012-0130-y355526323359769Search in Google Scholar

27. Neuzillet C, Tijeras-Raballand A, Cohen R, Cros J, Faivre S, Raymond E, et al. Targeting the TGF?? pathway for cancer therapy. Pharmacol Ther 2015; 147: 22–31.10.1016/j.pharmthera.2014.11.00125444759Search in Google Scholar

28. Jovanovic I, Radosavljevic G, Pavlovic S, Zdravkovic N, Martinova K, Knezevic M, Zivic D et al., Th-17 cells as novel participant in immunity to breast cancer. Serb. J. Exp. Clin. Res. 2010. 11: 59-6.Search in Google Scholar

29. Jonathan S. Levine, and Robert Burakoff. Extraintestinal manifestations of inflammatory bowel disese. Gastroenterology and hepatlogy. 2011; 7: 235-41.Search in Google Scholar

30. De Dombal FT, Watts JM, Watkinson G, Goligher JC. Local Complications of Ulcerative Colitis: Stricture, Pseudopolyposis, and Carcinoma of Colon and Rectum. British medical journal. 1966; 1: 1442-7.10.1136/bmj.1.5501.144218446405933046Search in Google Scholar

31. Lashner BA, Turner BC, Bostwick DG, Frank PH, Hanauer SB. Dysplasia and cancer complicating strictures in ulcerative colitis. Digestiv disease and Sciences. 1990; 35(3): 349-352.10.1007/BF015374132307080Search in Google Scholar

32. Bamias G, Martin C 3rd, Marini M, Hoang S, Mishina M, Ross WG, Sachedina MA, Friel CM, Mize J, Bickston SJ, Pizarro TT, Wei P, Cominelli F. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol 2003; 171: 4868-4874.10.4049/jimmunol.171.9.486814568967Search in Google Scholar

33. Camoglio L, Te Velde AA, Tigges AJ, Das PK, Van Deventer SJ. Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm Bowel Dis. 1998; 4: 285-90.10.1097/00054725-199811000-000059836081Open DOISearch in Google Scholar

34. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Bash-am B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233-240.10.1084/jem.20041257221279815657292Search in Google Scholar

35. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141.10.1038/ni1261Open DOISearch in Google Scholar

36. Ruddy MJ, Wong GC, Liu XK, Yamamoto H, Kasayama S, Kirkwood KL, Gaffen SL. Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem 2004; 279: 2559-2567.10.1074/jbc.M308809200Search in Google Scholar

37. O’Connor W Jr, Kamanaka M, Booth CJ, Town T, Nakae S, Iwakura Y, et al. A protective function for inter-leukin 17A in T cell-mediated intestinal inflammation. Nat Immunol. 2009; 10(6):603–609.10.1038/ni.1736Search in Google Scholar

38. S. Pflanz, J. C. Timans, J. Cheung et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 2002; 16: 779-790.10.1016/S1074-7613(02)00324-2Open DOISearch in Google Scholar

39. S. Lucas, N. Ghilardi, J. Li, and F. J. De Sauvage. IL-27 regulates IL-12 responsiveness of naïve CD4+ T cells through Stat1- dependent and -independent mechanisms. PNAS 2003; 100: 15047-15052.10.1073/pnas.253651710029990014657353Search in Google Scholar

40. Marek A, Brodzicki J, Liberek A, Korzon M. TGF-beta (transforming growth factor-beta) in chronic inflammatory conditions - a new diagnostic and prognostic marker? Med Sci Monit 2002; 8: RA145-RA151.Search in Google Scholar

41. Monteleone G, Kumberova A, Croft NM, McKenzie C, Steer HW, MacDonald TT. Blocking Smad7 restores TGFbeta1 signaling in chronic inflammatory bowel disease. J Clin Invest 2001; 108: 601-609.10.1172/JCI1282120940111518734Search in Google Scholar

42. Del Zotto B, Mumolo G, Pronio AM, Montesani C, Tersigni R, Boirivant M. TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn’s disease and ulcerative colitis. Clin Exp Immunol 2003; 134: 120-126.10.1046/j.1365-2249.2003.02250.x180884712974764Search in Google Scholar

43. Chunfang Gu, Ling Wu and Xiaoxia Li. IL-17 family: cytokines, receptors and signaling. Cytokine. 2013; 64: doi:10.1016/j.cyto.2013.07.022.10.1016/j.cyto.2013.07.022386781124011563Open DOISearch in Google Scholar

44. Yeon-Jeong Kim, Sun-Young Chang and Hyun-Jeong. Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease. Intest Res. 2015; 13: 105-111.10.5217/ir.2015.13.2.105441475125931994Search in Google Scholar

45. Györgyi Műzes, Béla Molnár, and Ferenc Sipos. Regulatory T cells in inflammatory bowel diseases and colorectal cancer. World J Gastroenterol. 2012; 18: 5688-5694.10.3748/wjg.v18.i40.5688348433623155308Open DOISearch in Google Scholar

46. ND Zdravkovic, IP Jovanovic, GD Radosavljevic, AN Arsenijevic, ND Zdravkovic, SLj Mitrovic, NN Arsenijevic. Potential Dual Immunomodulatory Role of VEGF in Ulcerative Colitis and Colorectal Carcinoma. Int J Med Sci 2014; 11: 936-947.10.7150/ijms.827725076849411358725076849Open DOISearch in Google Scholar